Finanzas de Alcon AG (ALC)ALCAlcon AG

Alcon AG (ALC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 29.2% of total sales, equivalent to $825.00M. Other significant revenue streams include Contact lenses and Ocular health. Understanding this composition is critical for investors evaluating how ALC navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Alcon AG maintains a gross margin of 60.50%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 1.56%, while the net margin is 0.00%. These profitability ratios, combined with a Return on Equity (ROE) of 2.94%, provide a clear picture of how effectively ALC converts its operational activities into shareholder value.

In the context of the broader market, ALC competes directly with industry leaders such as WST and GEHC. With a market capitalization of $31.97B, it holds a leading position in the sector. When comparing efficiency, ALC's gross margin of 60.50% stands against WST's 37.74% and GEHC's 41.17%. Such benchmarking helps identify whether Alcon AG is trading at a premium or discount relative to its financial performance.

Alcon's gross margin is strong at 60.50%, and its forward P/E ratio of 16.23 suggests potential for growth relative to its earnings. The company has shown resilience with a 5-day price change of +3.23%, despite a year-to-date decline of -14.72%.